Hautklinik und Poliklinik der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Address
- Langenbeckstr. 1, Gebäude 401, 55101 Mainz, Germany
Hautklinik und Poliklinik der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
The Department of Dermatology at the University Medical Center of Johannes Gutenberg University Mainz is a leading clinical research institution specializing in advanced dermatological conditions and innovative therapeutic approaches. The center demonstrates particular expertise in investigating novel pharmacological treatments for common yet challenging skin and hair disorders affecting diverse patient populations.
- Androgenetic alopecia and male pattern hair loss treatment development
- Topical androgen receptor antagonist therapies
- Pivotal efficacy and safety trials in dermatology
The department's research portfolio includes comprehensive double-blind, vehicle-controlled studies evaluating cutting-edge solutions for androgenetic alopecia, with a focus on determining optimal dosing regimens and long-term safety profiles. Their clinical trial infrastructure supports rigorous evaluation of novel compounds, contributing valuable evidence to advance therapeutic options for patients experiencing hair loss conditions that significantly impact quality of life.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hautklinik und Poliklinik der Universitätsmedizin der Johannes Gutenberg-Universität Mainz
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Clascoterone Solution Efficacy and Safety in Androgenetic Alopecia Treatment in Adult Males: A Phase 3 Randomized Double-Blind Study | Cassiopea S.p.A. | Phase III | Not Recruiting | Nov 2023 | Jul 2025 |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Clascoterone | 1 | Unknown | 2023-11-21 | 2023-11-21 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.